Stay updated on Immunogenic Nivolumab + Ipilimumab in Prostate Cancer Clinical Trial
Sign up to get notified when there's something new on the Immunogenic Nivolumab + Ipilimumab in Prostate Cancer Clinical Trial page.

Latest updates to the Immunogenic Nivolumab + Ipilimumab in Prostate Cancer Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedRecruitment status now indicates the study is no longer looking for participants. The page also adds new help sections (How to Read a Study Record, Common Questions, How to Join a Study) and updates the Interventions header from 'Intervention / Treatment' to 'Intervention/Treatment' with a revision note to v3.6.0.SummaryDifference0.5%

- Check19 days agoChange DetectedThe page revision was updated from v3.5.4 to v3.5.5, indicating a minor update to the page. The main study details and user-facing information remain the same.SummaryDifference0.1%

- Check27 days agoChange DetectedThe explicit 'Prostate cancer' label and the 'MedlinePlus Genetics' related topic linkage have been removed, along with the 'related topics' header. This changes how the study's subject is presented and which educational resources are shown to users.SummaryDifference0.2%

- Check34 days agoChange DetectedThe page now features Prostate cancer as a related topic and MedlinePlus Genetics as a related topics resource, linking the study to disease-specific background information and educational materials.SummaryDifference0.2%

- Check41 days agoChange DetectedRevision: v3.5.4 is now displayed, replacing v3.5.3. This indicates a small system/template update and does not modify the study content or its outcomes.SummaryDifference0.1%

- Check48 days agoChange DetectedDeleted the related topics block that listed Prostate Cancer and MedlinePlus Genetics. The page will no longer display these related informational resources as part of the study record.SummaryDifference0.2%

Stay in the know with updates to Immunogenic Nivolumab + Ipilimumab in Prostate Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Immunogenic Nivolumab + Ipilimumab in Prostate Cancer Clinical Trial page.